LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Mai S, Hodges A, Chen HM, Zhang J, et al. Cancer Res 2023;83:4047-4062.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mai S, Hodges A, Chen HM, Zhang J, et al. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res 2023;83:4047-4062.
PMID: 38098451